Statera BioPharma, a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, provided an update on the integration of the ImQuest BioSciences business unit and the status of the post-merger stock conversion process.
September 1, 2021
· 9 min read
